Back

An evaluation of genotoxicity and 90-day repeated-dose toxicity in rats of a Dracocephalum moldavica powdered extract

Choi, B.; Glavits, R.; Clewell, A.; Endres, J. R.; Hirka, G.; Vertesi, A.; Beres, E.; Szakonyine, I. P.

2025-07-21 pharmacology and toxicology
10.1101/2025.07.17.665188 bioRxiv
Show abstract

The safety of a powdered extract of Dracocephalum moldavica (Dracobelle Nu sd) was examined through a battery of in vitro and in vivo toxicological studies including a bacterial reverse mutation test, an in vivo mammalian micronucleus assay in male NMRI mice, and a subchronic toxicity study in Han:Wist rats. No mutagenic activity was observed in any of the tested bacterial strains with or without metabolic activation in the reverse mutation test, and no evidence of clastogenic or aneugenic activity was observed in the in vivo mouse micronucleus test. In the 90-day repeated dose oral toxicity study conducted in 80 (40 male/40 female) rats at dose levels of 0 (control), 250, 500, and 1000 mg/kg bw/day, no treatment related mortality or clinical signs of toxicity were observed, and no significant adverse effects attributable to the test item were found in any of the examined parameters in accordance with the OECD guidelines. The No Observed Adverse Effect Level (NOAEL) was determined to be 1000 mg/kg bw/day in male and female rats, the highest dose tested.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.